Table 1 Baseline Characteristics of Prevaccinated Asthma Patients on Both Groups
Characteristics | BCG Group (n = 20) | Placebo Group (n = 20) | P |
|---|---|---|---|
Sex (male/female) | 10 (50%)/10 (50%) | 8 (40%)/12 (60%) | 0.990 |
Age, yrs (mean ± SD) | 34.95 ± 11.55 | 34.90 ± 12.32 | 0.675 |
Body mass index, kg/m2 (mean ± SD) | 23.35 ± 3.16 | 22.97 ± 2.70 | 0.689 |
Old healed TBC lesions | 0 | 0 | 0.5 |
History of anti-TBC drugs | 0 | 0 | 0.5 |
Previous BCG vaccination scar | 14 (70%) | 15 (75%) | 0.517 |
Asthma triggers, no. (%) | |||
Dust mite | 12 (60) | 13 (65) | > 0.05 |
Cold air | 10 (50) | 8(40) | > 0.05 |
Pollutant | 9 (45) | 8 (40) | > 0.05 |
Drugs | 4 (20) | 4 (20) | > 0.05 |
Seafood | 2 (10) | 4 (20) | > 0.05 |
Pollen | 1 (5) | 0 | > 0.05 |
Duration of asthma, yrs (no. [%]) | |||
1-3 | 2 (10) | 3 (15) | > 0.05 |
3-5 | 4 (20) | 5 (25) | > 0.05 |
5-10 | 9 (45) | 8 (40) | > 0.05 |
> 10 | 5 (25) | 4 (20) | > 0.05 |
Asthma grading (GINA 2002) | |||
Mild persistent | 6 (30%) | 6 (30%) | 0.5 |
Moderate persistent | 14 (70%) | 14 (70%) | 0.5 |
Hemoglobin, g/dL | 14.76 ± 1.53 | 14.42 ± 1.68 | 0.508 |
Eosinophil in differentialcount, % | 9.85 ± 6.70 | 9.80 ± 6.52 | 0.190 |
Student t test for continuous variables; Fisher exact test for categorical variables. | |||